Transce3nd’s Cardinal Health CAH Stock Holding History

Transce3nd’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-63	Closed	-$10.6K	–	300
2025 Q2	$10.6K	Hold	63	–	–	﹤0.01%	557
2025 Q1	$8.68K	Hold	63	–	–	﹤0.01%	591
2024 Q4	$7.45K	Buy	+63	New	+$7.36K	﹤0.01%	826

Other funds holding CAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Transce3nd's CAH Position: Q3 2025 in Review

Transce3nd sold out of Cardinal Health (CAH) in Q3 2025, closing a stake of 63 shares — an estimated $10.6K sold.

Transce3nd first reported a position in CAH in Q4 2024 and held it in 3 quarters. The position peaked at $10.6K in Q2 2025. 1,222 funds tracked by Wall St. Rank hold CAH as of Q3 2025.

Transce3nd reported no remaining Cardinal Health position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 63 Cardinal Health shares in Q3 2025, an estimated $10.6K.
Transce3nd first reported a position in Cardinal Health in Q4 2024 and held it in 3 quarters.
Transce3nd's Cardinal Health position peaked at $10.6K in Q2 2025.
1,222 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.